Join us in redefining pathology
"The Pap Smear Pre Screening Tool"
​
At identify.bio, we are pioneering the future of pathology by merging cutting-edge technology with medical expertise to transform how diseases are diagnosed and treated. Founded in 2021, our mission is to empower pathologists, researchers, and clinicians with innovative digital tools that enhance diagnostic accuracy, streamline workflows, and accelerate the journey toward personalized patient care.
OUR VISION
​We envision a world where digital pathology bridges the gap between data and discovery, enabling faster, more precise diagnoses that improve outcomes for patients globally. By harnessing the power of artificial intelligence, cloud-based collaboration, and advanced imaging, we aim to redefine the standards of pathology and contribute to the next era of precision medicine.
MILESTONES
October 2024
Company Incorporation
October 2021
Presented research on validation of PSx2 with The Catholic University of Korea at ASDP.
Obtained ISO 13485 Certification
August 2023
March 2024
Selected to participate in Global Partnership of Artificial Intelligence and present research to Minister of Electronics and Information Technology, Honourable Shri Rajeev Chandrashekharan
December 2023
Poster of validation of PSx2 with The Ohio State University at USCAP.
MEET THE TEAM
FOUNDERS
.jpg)
Rushabh is the co-founder and CEO of identify.bio responsible for day-to-day operations of the company.
His past experience includes leading multi-disciplinary teams building big data and AI applications for leading global retailers and consumer brands.
He has an undergraduate degree from Babson College, MA, USA and an executive postgraduate degree in analytics and AI from IIM, Bangalore, India.
Rushabh Mehta
Founder & CEO
Rushabh Mehta
Co-founder & CEO
Rushabh is the co-founder and CEO of identify.bio responsible for day-to-day operations of the company
Co-founder
Akshay currently serves as Director at SIRO Clinpharm, in charge of Global Business Development Activities and Operations. Akshay provides oversight, leadership, and guidance in the management of the company.He spent the first 4 years of his career at Bharat Serums and Vaccines. He then joined SIRO Clinpharm in 2018 to look after the Global Business Development and Operations.Akshay has an undergraduate degree in Economics and Mathematics from Emory University, GA, USA.
Akshay Daftare
Founder
Akshay Daftary
Akshay currently serves as Director at SIRO Clinpharm, in charge of Global Business Development Activities and Operations.
SCIENTIFIC ADVISORY COMMITTEE
Dr. Girish Muzumdar
Dr. Girish Muzumdar (MD Pathology) serves as the Medical Director of identify.bio. He is also currently the Head of Surgical Pathology at the Bombay Hospital Institute of Medical Sciences. He has previously served as consultant Histopathologist to some of the largest central laboratories in India most recently at Suburban Diagnostics and earlier at Metropolis. Dr. Muzumdar was the Head of Surgical Pathology at the Asian Cancer Institute for 7 years. Dr. Muzumdar has published more than 30 research papers in reputed journals and has over 35 years of experience in surgical pathology and cytopathology.
Dr. Gautam Daftary
A medical doctor by qualification, Dr. Daftary is a second-generation entrepreneur with a successful record of accomplishment of starting various companies in the healthcare domain – from Diagnostics to Healthcare Delivery. He has founded several companies like Bharat Serums and Vaccines Private Limited, Siro Clinpharm Private limited and Aksigen Hospital Care, among several others. Some of the notable contributions from BSV are the equine biologicals for anti-toxins (anti snake venom serum) and anti-virals (anti-Rabies serum), nanotechnology-based Amphotericin emulsion for Kala Azar, and biotechnology-derived monoclonal Anti D in hemolytic disease of the newborn, monoclonal tetanus immunoglobulin for treatment of tetanus and Ulinastatin for treatment of sepsis and Acute Pancreatitis. Until divesting his equity stake in BSV to a large US-Based private equity firm, Dr. Daftary was primarily responsible for research and development, manufacturing and global sales in the organization Created a global scale research, development and manufacturing capabilities for cost effective and quality equine based anti-venoms and immunoglobulins biological product range Established a world-class Biotech research and manufacturing infrastructure with several first in the world products for specific life-threatening diseases. Pioneer in developing and commercialization novel drug delivery systems with several first-time products – globally and in India.
Dr. Nitin Gangane
Dr. Nitin Gangane (MD,DNB,FUICC,FICP,FAMS,Ph.D) is currently the Vice-Chancellor of Jawaharlal Nehru Medical College. He was previously the Dean of Mahatma Gandhi Institute of Medical Sciences (MGIMS), Sevagram, Wardha, Maharashtra. He has been awarded Yamagiwa-Yoshida Memorial International Cancer Study Grant by UICC to work at International agency for research on cancer (WHO), Lyon, France and NIDCR/NIH, Bethesda, USA. He has also received Fellowship from Association of Nordic cancer society’s and the Indian Council of Medical research. He has more than 180 national and international publications to his credit. Dr. Gangane has been the Principal Investigator in seven research projects and co-investigator in 12 projects funded by international bodies like IARC (WHO), UICC, NIH, University of Umea and national funding agencies like ICMR, UGC, and DST. He has been a member of Governing Bodies such as Indian Council of Medical Research. He was also the Member of Management and Academic Council of Maharashtra University of Health Sciences. He has earlier worked on Senate of Maharashtra University of Health Sciences, Nashik, Maharashtra. He was the President of Maharashtra chapter of Indian Association of Pathologists and Microbiologists from 2006 to 2009
Dr. Anupama Gupta
Dr. Anupama Gupta is a professor and the Head of Department (Pathology) at the Mahatma Gandhi Institute of Medical Sciences, Sevagram, India. An alumnus of Gajra Raja Medical College, Gwalior, Dr Anupama obtained MD (Pathology) in 1994 and joined MGIMS as a lecturer in 1995. Trained in Oncopathology at Tata Memorial Hospital, Mumbai and keenly interested in Cytopathology, she was instrumental in establishing a flowcytometry laboratory in her department. Dr. Gupta has conducted and published more then 10 primary research projects. She is the Principal investigator for the ‘Population Based Cancer Registry’ in Wardha. It registers all the confirmed and suspected cases of cancer occurring in the Wardha district, including the incidence and mortality. It also follows all the patients of common cancers for compliance with treatment and the survival status.